NQO1 is highly expressed in human and mouse HCC cells, promoting proliferation and mediating tumor growth by activating the PI3K/AKT and MAPK/ERK signaling pathways, which suggests that NQO1 can be used as a therapeutic target for HCC [7]. This evidence concerns the gene AKT1 and hepatocellular carcinoma.